Which vaccines are recommended for individuals aged 65 and older?

Individuals aged 65 and older are recommended to receive the pneumococcal vaccines, specifically PPSV23 and PCV13. PPSV23 (Pneumococcal Polysaccharide Vaccine 23-valent) and PCV13 (Pneumococcal Conjugate Vaccine 13-valent) are crucial in preventing pneumococcal diseases, which can include pneumonia, meningitis, and bloodstream infections, particularly in older adults who are at an increased risk due to age and potential underlying health issues.

The recommendation for both vaccines is based on the understanding that older adults have a higher susceptibility to pneumococcal infections and the complications that can arise from them. The combination of PCV13 and PPSV23 helps to provide broader coverage against serotypes of Streptococcus pneumoniae, the bacteria responsible for these infections.

While the other vaccines listed in the options may be important for different age groups or populations, they are not specifically indicated for individuals over the age of 65 in the context provided. For example, DTP (Diphtheria, Tetanus, Pertussis) is typically administered in younger populations and is less prioritized for those in this age group. Similarly, MMR (Meas